Allogeneic Stem Cell Donation

Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and ...  Show more

Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate Editor David Simel, MD, MHS, is joined by review coauthor Josef Smolen, ...  Show more

In today’s episode, we welcome back Dr. Amar Kelkar for part 1 of our two-part discussion on allogeneic transplant. In this episode, we discuss the fundamental approach to patient selection and stem cell source selection. As you all know from this series, allogeneic transplant ...

NSGC Podcast Subcommittee members Mary Pat Bland and Ryan Kuehl discuss genetic counseling considerations related to bone marrow transplant (BMT) with genetic counselors Kaylee Dollerschell, MS, CGC and Rebecca Tryon, MS, MA, CGC. During this episode, our speakers provide backgro ...  Show more

Jimi Olaghere feels like he’s been reborn after a pioneering new treatment for sickle cell disease. Scientists have engineered his blood to overcome the disease that left him in constant pain. I speak to Jimi about his experience and to his doctors about what this could mean for ...  Show more

In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemi ...  Show more